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Defending Your DNA: Combating 
Threats both Foreign and 
Domestic
James mCisaaC
We are under constant assault from forces capable of damaging our DNA. The genetic code of DNA is made up of four nucleotides: adenine (A) which bonds with thymine (T) and guanine (G) which bonds with cytosine (C). If something happens to upset 
this normal pairing or the nucleotides themselves, our body must spring to action 
and respond to the damage. When damage to nucleotides prevents the normal rep-
lication machinery from doing its job, enzymes like the Y-family polymerases are 
called in. A special mechanism allows them to identify damage and insert the cor-
rect nucleotide or bypass the lesion to continue replicating a new strand of DNA. If 
not bypassed correctly, the result is a mutation in our genetic code that could lead 
to cancer. Understanding how our body reacts to genetic damage on a molecular 
level, will aid the development of future anti-cancer therapies.
Introduction:  
Every day of your life there are soldiers that stand between you and certain 
danger. These soldiers are hidden from sight; waiting, watching, and always 
ready to protect you. They have abilities that set them apart from their peers 
and allow them to do the jobs that no one else could, but they do so with little 
to no oversight. What if, one day these soldiers act in a way to protect you, 
but something goes terribly wrong? What if these defenders make a mistake 
that puts your life in jeopardy? This is not the latest script for a Hollywood 
movie, but a scene that plays out every day inside every cell in your body. The 
stars of this real life action role are a group of enzymes commonly referred 
to as translesion polymerases. Every day, your DNA is under constant attack 
from enemies both foreign and domestic, or in biological terms, exogenous 
and endogenous, respectively. These attacks, when successful, often result in 
some type of damage. When DNA is copied, this damage, which is often 
referred to as a lesion, prevents the normal replication machinery from doing 
its job until the lesion is fixed by the DNA repair machinery of the cell. If 
the damage is too extensive, it then becomes the responsibility of the Special 
Forces enzymes that are able to perform a function called translesion synthesis 
(TLS). When these TLS polymerases step in and do what needs to be done to 
continue the DNA replication, errors in the code can be created. These errors 
are known as mutations and can be dangerous depending on which genes are 
affected. The mutations in DNA may translate into mutations in proteins, 
which may alter the way a protein functions or prevent it from working com-
pletely. The major focuses of this paper are the consequence of mutation, 
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types of damage to our DNA, and the enzymes responsible for 
coping with the damage.
Consequences of DnA damage:
The most well known consequence of mutation in DNA is 
cancer. In the 2012, it was estimated that an American was 
diagnosed with cancer every 19 seconds (1). 
Long before a doctor can see evidence of a tumor, the pro-
cess of cancerogenesis starts as a single genetic mutation. Our 
cells have an amazing array of defensive mechanisms to prevent 
these mutations from leading to cancer (2). Unfortunately, this 
becomes a numbers game in many cases. For 75 to 80% of 
cancer patients, their disease is the result of some external fac-
tor they came in contact with on a daily basis (3). The protec-
tive and repair mechanisms within our bodies can only cope 
with so much before failing or making a mistake. These genetic 
mutations can begin in the form of a DNA lesion, which is 
a structural anomaly in our genetic code caused by exposure 
to a residue or other harmful event capable of impacting our 
DNA. Our cells can either remove the lesion or attempt to 
replicate past it with special enzymes. If this damage is not 
properly handled a mutation may be present in future copies 
of the DNA. The impact a mutation will have on the body has 
more to do with how many are present, the gene possessing the 
mutation and what its normal function involves. The damage 
to our DNA comes in many sources and forms.
shape of a double helix. Anything that disrupts this pairing or 
alters the shape of the nucleotides is known as a lesion. Some 
of the lesions found in DNA are abasic sites, interstrand & 
intrastrand crosslinks and adducts (8). 
Abasic sites are lesions in which one member of a complemen-
tary pair of nucleotides is missing or twisted out of the DNA 
helix (7). These lesions can occur as the result of internal and 
external agents. There are several chemical interactions that 
could result in a nucleotide being excised from the DNA mol-
ecule. Enzymes could eject a nucleotide, or it could even hap-
pen spontaneously (7). When a nucleotide is missing or twisted 
out of alignment it causes a local and usually minor shift to the 
normal helical shape of a DNA molecule (7). This presents a 
two-fold problem for the normal replicative machinery. The 
normal enzymes must cope with the geometric distortion in 
the shape of the DNA molecule and the missing piece in the 
sequence to be copied.
Interstrand and intrastrand crosslinks are other types of lesions 
formed when nucleotides develop covalent bonds with another 
nucleotide instead of the normal pairing with its complemen-
tary nucleotide (6). When nucleotides on opposite strands 
form covalent bonds, they prevent the enzyme DNA helicase 
from performing its role of splitting the strands for replication 
(11). When these interstrand crosslinks or ICLs occur the cell 
will die if this damage is not repaired. Intrastrand crosslinks 
are formed when nucleotides on the same side form a covalent 
bond. These bonds can be caused by a variety of endogenous 
and exogenous agents. Thymine-thymine crosslinks are caused 
by exposure to ultra-violet radiation and are usually associated 
with different types of skin cancer (Fig 2). One way to remove 
this lesion is to eject one or both of the cross-linked nucleotides 
creating an abasic site (4). Alternatively, TLS polymerases can 
be used to bypass this lesion and allow replication to continue 
and prevent cell death (2).
Adducts are lesions in which DNA becomes covalently bond-
ed to a molecule (5). These malicious chemicals can originate 
from a variety of sources. Given that there are so many poten-
tial chemical interactions that could occur, there are a tremen-
dous number of possible adducts; a few examples are shown 
in Figure 3. Adducts distort the geometric shape of DNA to 
varying extremes, depending on the size of the adduct itself 
and where it occurs within the molecule (6). Normal replica-
tion enzymes are unable to synthesize new strands of DNA 
past these adducts, and enzymes like the Y-family of polymer-
ases are called in to do the job (6). Etheno-dA is a lesion that 
can lead to mutation when cells try to copy DNA containing 
it (2). When hydroxyl-2-nonenal (or HNE for short) attacks 
a normal molecule of adenine, it forms a new bond that can 
Figure 1 DnA nucleotides base-pairing. DNA is composed of four nucleo-
tides whose order codes specific genetic messages in the double helix G (gua-
nine) with C (cytosine)  and A (adenine) with T (thymine). Each nucleotide 
is composed of a base (depicted with a chemical formula), sugar (depicted 
with the word sugar) and a Phosphate (omitted for clarity). The G-C and 
A-T bonding pattern determines the regularity of the DNA shape. Any mi-
spairing or nucleotide chemical modification could cause a distortion of the 
double helix. This image was generated with ChemBioDraw Ultra.
types of DnA Damage:
Our genetic code is determined by the sequence of four nucle-
otides: adenine (A), thymine (T), guanine (G), and cytosine 
(C) (Fig. 1). Under normal conditions each nucleotide only 
pairs with one other nucleotide. Adenine bonds with thymine 
and guanine bonds with cytosine. Each molecule bonds to 
its complementary pair in a specific way, creating the regular 
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produce the etheno-dA lesion, altering the original structure 
in a way with which normal replication processes cannot cope 
(Fig. 3). The external influences that can generate these lesions 
are wide and varied, from the consumption of alcohol and cof-
fee to cigarettes (9). Because of the change to the molecule of 
adenine, as shown in Figure 2 it is possible for the TLS poly-
merase to misread the nucleotide and incorporate a cytosine 
instead of a thymine leading to mutation (9). In order for cells 
to survive genetic damage they need special polymerases with 
their own set of rules.
translesion Synthesis (tLS) polymerases:
In humans, translesion synthesis is largely attributed to five 
polymerases. Four of the polymerases are from the Y-family: 
Kappa, Eta, Iota and Rev1. Polymerase Zeta is from the B-
family (6). Each polymerase has been shown to perform cer-
tain roles both individually and while working in tandem. 
The Y-family polymerases closely resemble each other, though 
with enough variation to perform different tasks (9). As with 
all proteins, function is directly related to structure. While 
these enzymes perform related tasks, the lesions they bypass 
are structurally different and require their respective bypass 
enzymes to have sufficient variation in their active sites to ac-
commodate these lesions (Fig 4). These enzymes have been de-
scribed as resembling an open right hand, and the regions of 
this enzyme have been labeled according to that analogy (Fig 
5). They have a thumb that holds the DNA in a region called 
the minor groove. The polymerase finger(s) lie over the tem-
plate nucleotide to be copied. The palm creates a bond with 
the phosphate backbone of the DNA molecule. There is a 
section of the enzyme called the N-digit or little finger which 
has some variation in functionality between the enzymes. The 
wrist or polymerase associated domain (PAD) contacts the ma-
Figure 2 Distortion of a DnA by thymine-thymine  Dimer. Double- 
stranded DNA adopts a regular helical shape driven by regular basepairing 
between complementary DNA bases. Thymine-Thymine dimers (circled in 
black) arise from crosslinking two adjacent Thymine bases upon UV irradia-
tion and alter the overall shape of the DNA molecule. This image was gener-
ated by PyMOL. . 
Figure 3 Examples of adducted nucleotides. Adducted nucleotides are 
chemically modified versions of Adenine, Thymine, Cytosine and Guanine. 
The chemical modification in each adduct is highlighted with a grey oval. 
The displayed chemical formulas were generated using ChemBioDraw Ultra.
A
B
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jor groove region on DNA (9). Some obstructions prevent a 
single enzyme from both bypassing a lesion and restarting the 
replication process for the rest of the DNA strand to be copied; 
and therefore must work with a partner (9). If TLS is done 
correctly, it allows DNA to replicate, despite the initial pres-
ence of an anomaly, though this replication is not always error 
free. The error rate for a TLS polymerase is between 10-2 and 
10-4, while normal replication polymerases have an error rate 
between 10-5 and 10-7 (3). It is important to note that because 
TLS polymerases do not have any proofreading component, 
like polymerases involved in normal replication, this can result 
in mutations that are not corrected. 
Pol Eta is capable of working independently or in conjunc-
tion with one of its sibling enzymes. This enzyme has proven 
efficient at dealing with lesions caused by ultra-violet rays (9). 
Cyclobutane pyrimidine dimers or CPDs are lesions caused by 
UVB and UVC rays, and Pol eta is the most reliable at by-
passing these lesions without mutation (9). It can also per-
form translesion synthesis past some types of intercross links 
or ICLs. Bulky adducts like 8-oxoguanine are bypassed by this 
polymerase also. The thymine-thymine crosslink, like that 
shown in figure 2 which can lead to skin cancer, is bypassed by 
this enzyme along with Rev1 (4). Pol eta is able to insert two 
adenines across from the two thymines, but it requires Rev1 to 
restart the replication process (4).
Pol Iota is considered the highest fidelity, or most faithful poly-
merase in the Y-family (9). Pol iota is also capable of bypassing 
thymine-thymine crosslinks though not as well as Pol eta (9). 
Incorporation of the correct nucleotide is more efficient with 
adenine and guanine as the template than cytosine and thy-
mine (9). It has been shown that abasic sites can be bypassed 
by Pol iota with good efficiency. As well as certain guanine ad-
ducts, and a wide variety of adenine adducts. Though capable 
of bypassing several lesions, it is often inefficient at extending 
replication past the lesion and must work with a partner to 
perform both functions (9).
Pol Kappa is considered to be fairly high fidelity for a Y-family 
polymerase. It has been shown to work with other polymerase 
enzymes, where it takes on the role of extending replication 
past the lesion site (9). It has proven effective for certain types 
of ICS bypass (4). Pol kappa is well known for being able to 
bypass bulky guanine adducts like Benzo(a)pyrene diolepoxide 
(BPDE), and adduct associated with cancer caused by cigarette 
smoke (2). It will also work with other enzymes like Rev1 when 
bypassing adducts like thymine glycol, where Rev1 is respon-
sible for restarting the replication process past the lesion (2). 
Pol kappa has also been shown to both bypass abasic sites and 
cause them (2). When it causes an abasic site by removing a 
nucleotide it often causes another problem known as a frame-
shift error or mutation (9). These frame-shift errors are often 
the result of an adjustment caused by a misinsertion of a nucle-
otide. The enzyme tries to force out the incorrect sequence and 
reinsert it across from the next appropriate nucleotide (9). This 
can cause slight distortion to the frame of the DNA helix even 
after replication has restarted.
Figure 4 Y-Family DnA polymerases. A) Pol. Eta (PDB 2R8J)  B) Pol. 
Iota (PDB 3GV8) C) Pol. Kappa (PDB 3IN5) D) Rev1(PDB 2AQ4). Each 
polymerase is visualized interacting with DNA to give a perspective on the 
size of each enzyme and its active site with respect to the other enzymes in 
the family. These four polymerases are structurally different as seen by the 
above images. The variation in structure allows for lesions of various sizes to 
fit within the active site of the appropriate enzyme. The image was generated 
using PyMOL Molecular Graphics System using crystal structures obtained 
from the PDB. 
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The complete role of Rev1 is still being uncovered. Rev-1 typi-
cally binds to a guanine and inserts a cytosine when reading and 
copying DNA (11). Although Rev1 prefers inserting a cytosine 
opposite a guanine, it will bind to other sites, although much 
less efficiency is observed (6). When Rev1 interacts with the 
DNA helix, the amino acid glycine forms specific interactions 
on guanine (6). Once bonded to the guanine, Rev1 is then 
able to insert a cytosine into the new strand of DNA to allow 
proper coding to continue. If Rev1 does not do its job in this 
fashion, the new strand will contain a potentially hazardous 
mutation. Bypassing guanine adducts is what this polymerase 
is best known for, which is a poor choice because it focuses on 
one aspect of what this enzyme is capable of. Rev1 has been 
shown to possess the unique ability of interacting with the rest 
of the TLS polymerases. The N-digit on Rev1 allows it to inter-
act with other enzymes and accessory proteins (4). With these 
protein interactions Rev1 makes it possible for lesion bypass to 
occur with the continuation of the replication process without 
stalling and putting the DNA strand in more jeopardy. 
It is nearly impossible not to talk about Pol Zeta when speaking 
on the subject of translesion synthesis. The other two enzymes 
in the B-family have a proofreading functionality that, like the 
Y-family, Pol Zeta lacks. While it may lack proofreading, it is 
still a higher fidelity polymerase than most of the Y-family (5). 
It has been experimentally determined that Pol zeta can work 
with other enzymes to allow replication to continue past the 
site of a lesion, or a bypassed lesion. Pol Zeta is structurally dif-
ferent from the Y-family, as it is composed of only two subunits 
called Rev3 and Rev7 (4). Pol zeta in conjunction with Rev1 is 
blamed for many of the mutations found in eukaryotes (12). 
These two enzymes together are able to bypass many lesions 
and incorporate the wrong nucleotide.
Looking to the future:
According to Sun Tzu, “the highest form of generalship is to 
balk the enemy’s plans, the next best is to prevent the junction 
of the enemy’s forces, the next in order is to attack the enemy’s 
army in the field, and the worst policy of all is to besiege walled 
cities” (13). Fighting a walled city is exactly what we are doing 
when we attack cancer that has already formed a tumor. This 
city has an ever-increasing population, and its own blood ves-
sels supply it with all of the resources it needs to fight back. We 
are often forced to fight cancer with weapons that attack the 
entire body, not just the tumor. As we are exposed to chemo-
therapy drugs, they create the risk of developing new cancerous 
mutations. In no way is this a wise strategy for winning a war. 
With more research aimed at understanding the mechanics be-
hind a cell becoming cancerous, we can switch our tactics and 
focus on balking the enemy’s plans.
 Cancer is an enemy that does not confine its damage to the 
person it attacks, but unleashes its malicious influence in some 
way upon everyone in the victim’s life. During 2010, American 
families spent an estimated $124.57 billion dollars on cancer 
care (1). This enormous financial burden is the result of doc-
tor visits, clinic treatments, procedures, lab tests, imaging tests, 
radiation treatment, drug costs, hospital stays, surgeries, and 
home care (1). The financial breakdown was a lot to fit into 
a sentence; imagine fitting it into your life. What if there was 
another way to fight cancer?  Without a better understanding 
of this process we will never learn to ask better questions. As 
more research is done to understand the role each enzyme plays 
during lesion bypass, the closer we come to developing targeted 
treatments and more comprehensive preventative measures. 
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